Extracellular RNA Markers of Liver Disease and Cancer
Megadott ok: Ran out of funds
A legfontosabb adatok
- Hol
- Chicago, Jacksonville, Richmond és Rochester (Egyesült Államok)Mind a 4 helyszín megnézése
Helyszínek itt: Egyesült Államok
- The University of Chicago Medical CenterChicago, Egyesült ÁllamokNo longer taking part
- Mayo Clinic FloridaJacksonville, Egyesült ÁllamokNo longer taking part
- McGuire VA Medical CenterRichmond, Egyesült ÁllamokNo longer taking part
- Mayo ClinicRochester, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- Mayo Clinic
- Azonosító
- NCT02908048
- A regiszteradat frissítve
- 2026. május 5.
- Eredeti leírás
The study will examine and evaluate the use of extracellular RNA in blood as markers for the diagnosis of liver disease or cancer, and as markers for prediction of response to treatment or recurrence of cancer after surgeryA teljes eredeti leírásKevesebb
The study will examine and evaluate the use of extracellular RNA in blood as markers for the diagnosis of liver disease or cancer, and as markers for prediction of response to treatment or recurrence of cancer after surgery
Bevonási feltételek: Lab results from within the previous 90 days; Diagnosis of HCC or biliary tract cancer; Diagnosis of cirrhosis based on histology, imaging, or ultrasound; Diagnosis of a chronic liver disease without cirrhosis.
Kizáró feltételek: Prior solid organ transplant; Prior solid organ transplant; Previous or current cancer history within the past 5 years (excluding non-melanoma skin cancer); Previous cancer history with the last 5 years (excluding non-melanoma skin cancer), participation in a treatment trial for HCC.